Background. The histopathological classification and staging system for uterine sarcoma
(US) were revised in 2003 and 2009, respectively. However, there is currently no consensus …

The remit of this guideline is to collate and propose evidence-based guidelines for the
diagnosis and management of uterine cancer. This document covers all uterine cancers of …

OBJECTIVE.: Uterine leiomyosarcoma (LMS) is usually diagnosed after surgery for
leiomyoma; thus tumor morcellation frequently occurs. We evaluated the impact of tumor …

Background Uterine carcinosarcomas are rare and highly aggressive tumours. Although
surgery is the cornerstone of treatment, the extent of the procedure remains controversial …

Background The purpose of this study was to evaluate the impact of tumor morcellation on
the outcomes of patients with apparently early low-grade endometrial stromal sarcoma …

Recently, there has been an intense discussion about the issue of fibroid and uterine
morcellation in relation to the risk of unrecognized uterine sarcoma spread. Morcellation can …

Background Superficial leiomyosarcoma (LMS) is a rare tumor with important clinical,
pathologic, and treatment features. Previous LMS studies have included few patients …

OBJECTIVES: Uterine carcinosarcoma (CS) is a rare but aggressive malignancy frequently
associated with extrauterine metastasis at the time of diagnosis. The objective of this study …

Endometrial stromal tumors are uncommon mesenchymal tumors of the uterus. The
classification of these tumors has evolved and the most current World Health Organization …

Background: Uterine cancer (UC) is one of the leading gynecologic neoplastic disorders in
the United States (US), of which over 80% are endometrioid adenocarcinomas (EA). In …